Douglas Stuart Greene

Title: Douglas Stuart Greene: Innovator in Neonatal Care

Introduction

Douglas Stuart Greene is a notable inventor based in Newtown, PA (US). He has made significant contributions to the field of neonatal care, particularly in the treatment of premature infants. With a total of 5 patents, Greene's work focuses on improving health outcomes for vulnerable populations.

Latest Patents

One of Greene's latest patents is a method for identifying and treating premature infants at risk for bronchopulmonary dysplasia (BPD). This patent outlines methods for identifying infants who are most likely to benefit from inhaled nitric oxide therapy for the prevention of BPD. Additionally, it provides strategies for recognizing infants who are not at risk and should avoid potential toxicity from such treatments. Another significant patent involves methods of administering high concentrations of nitric oxide, particularly above 2,000 ppm, with specific dosing rates. This innovation includes the use of portable devices for delivering therapeutic gases, enhancing the accessibility of treatment for patients.

Career Highlights

Throughout his career, Greene has worked with prominent companies in the healthcare sector, including Mallinckrodt Hospital Products and Mallinckrodt Pharmaceuticals. His experience in these organizations has allowed him to develop and refine his innovative approaches to neonatal care.

Collaborations

Greene has collaborated with notable professionals in his field, including Joseph J Medicis and Jim Potenziano. These partnerships have contributed to the advancement of his research and the successful implementation of his patented methods.

Conclusion

Douglas Stuart Greene's contributions to neonatal care through his innovative patents demonstrate his commitment to improving the health of premature infants. His work continues to influence the field and offers hope for better treatment options in the future.